Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Behav Pharmacol. 2022 May 10;33(4):291–300. doi: 10.1097/FBP.0000000000000676

Male and female rats exhibit comparable gaping behavior but activate brain regions differently during expression of conditioned nausea

Alyssa Bernanke 1, Samantha Sette 1, Nathaniel Hernandez 1, Sara Zimmerman 1, Justine Murphy 1, Reynold Francis, Zackery Reavis 1, Cynthia Kuhn 1
PMCID: PMC9354039  NIHMSID: NIHMS1789674  PMID: 35621171

Abstract

Twenty-five to fifty percent of patients undergoing chemotherapy will develop anticipatory nausea and vomiting (ANV), in which symptoms occur in anticipation of treatment. ANV is triggered by environmental cues and shows little response to traditional antiemetic therapy, suggesting that unique neural pathways mediate this response. Understanding the underlying neural mechanisms of this disorder is critical to the development of novel therapeutic interventions. The purpose of the present study was to identify brain areas activated during ANV and characterize sex differences in both the behavior and the brain areas activated during ANV. We used a rat model of ANV by pairing a novel context with the emetic drug lithium chloride (LiCl) to produce conditioned nausea behaviors in the LiCl-paired environment. We quantitated gaping, an analogue of human vomiting, after acute or repeated LiCl in a unique environment. To identify brain regions associated with gaping, we measured c-fos activation by immunochemical staining after these same treatments. We found that acute LiCl activated multiple brain regions including the supraoptic nucleus of the hypothalamus, central nucleus of the amygdala, nucleus of the solitary tract and area postrema, none of which were activated during ANV. ANV activated c-fos expression in the frontal cortex, insula and paraventricular nucleus of the hypothalamus of males but not females. These data suggest that therapies such as ondansetron which target the area postrema are not effective in ANV because it is not activated during the ANV response. Further studies aimed at characterizing the neural circuits and cell types that are activated in the conditioned nausea response will help identify novel therapeutic targets for the treatment of this condition, improving both quality of life and outcomes for patients undergoing chemotherapy.

Keywords: Conditioned nausea, C-fos, Sex differences

Introduction

Chemotherapy-induced nausea and vomiting (CINV) is one of the most common and debilitating side effects of cancer treatment 15. Approximately 25–50% of patients will develop anticipatory nausea and vomiting (ANV), in which patients experience symptoms prior to administration of the toxic drug 2, 612. ANV is a conditioned response in which contextual stimuli associated with previous chemotherapy, rather than chemotherapy agents themselves, trigger the onset of nausea and/or vomiting. The likelihood of ANV increases with the emetogenicity of the chemotherapy agent, the incidence of delayed nausea and vomiting, increasing numbers of chemotherapy treatments, and sex (women more affected) 2, 911, 13. ANV can be refractory to treatment, reducing quality of life and, more importantly, resulting in cessation of treatment. However, little is known about the neurobiological mechanisms underlying this disorder. As such, this condition represents a critical unmet need that affects vulnerable patients, and women particularly.

The current standard of therapy for CINV consists of a cocktail of preemptive treatment with a 5HT3 antagonist, the atypical antipsychotic olanzapine (D2, 5HT2, and 5HT3 antagonist), the NK1 antagonist aprepitant, and the steroid dexamethasone 5, 1418. Blockade of dopamine (D2) and serotonin (5HT3) receptors in the area postrema (AP) and NK1 receptors in the nucleus of the solitary tract (NTS) block the ascending sensory stimuli that trigger vomiting 1929. These sites are especially effective at blocking incoming afferent signals from the gut (via the AP) and the vagus nerve (via the NTS), and the acute nausea triggered by toxic substances. Animal literature has also shown that completely effective blockade of acute nausea can substantially reduce or prevent expressions of conditioned nausea including gaping30, 31. Conversely, similar studies show that these drugs are less effective at treating ANV once it has developed, suggesting that the mechanisms of contextual nausea/vomiting are fundamentally different than those induced by a toxin. However, the neural circuit that controls expression of ANV is poorly understood12, 32. Promising studies have implicated the ability of cannabinoids and related fatty acids to blocked expression of conditioned gaping through actions in the ventral pallidum and insular cortex33, 34. But beyond these interesting studies, the brain areas involved in ANV are poorly characterized.

The present study took a non-pharmacologic approach to further investigate the possibility that that ANV is controlled by a distinct neural circuit from that of acute vomiting. LiCl activates the nausea circuit in rats through direct activation of the area postrema (AP). The AP activates the vomiting response through coordinated activation of brain regions, including the nucleus of the solitary tract, parabrachial nucleus, amygdala, paraventricular nucleus, supraoptic nucleus, insula, and frontal cortex3539. These regions are responsible for the neuromuscular and autonomic responses in the vomiting circuit in both rats and humans 40, 41.

We hypothesized that brain regions activated during the acute nausea response are not activated by the conditioned nausea response, while brain regions that activated in the contextual stimulus would respond to the LiCl conditioned context. To test this hypothesis, we examined the neural activation of multiple brain regions associated with acute nausea, such as the area postrema (AP), nucleus tractus solitarius (NTS), central and basolateral nuclei of the amygdala (CeA, BLA), and supraoptic nucleus (SON) which we predicted are not activated during conditioned nausea, and regions that are responsive to contextual cues, such as the ventromedial prefrontal cortex (vmPFC), agranular and granular insula (aIC, gIC), the nucleus accumbens core (NAcC) and the paraventricular nucleus of the hypothalamus (PVN) which we predicted would respond to the LiCl-conditioned context.

In order to better understand how the conditioned nausea response differs from the acute response, we utilized a rodent model of ANV that used gaping to assess nausea and activation of the immediate early gene c-fos to define brain areas activated by the contextual stimuli associated with treatment. In this paradigm, a novel context (test cage) was repeatedly paired with the emetogenic agent LiCl. LiCl was selected for its quick onset and relatively short half-life, high emetogenicity, and established use in conditioned nausea paradigms4246. Rats and other rodents, like humans, express both acute and conditioned behavioral responses to emetic agents like LiCl. Rats lack anatomical and likely neurological drivers of emesis and thus do not vomit47. However, they exhibit gaping, a behavioral response that resembles human vomiting, engaging the same muscles as vomiting and responsive to drugs that reduce nausea and vomiting in humans4850. Conditioned gaping (CG) is a behavior exhibited by rats after repeated pairings of an emetic agent with a contextual stimulus, such as a novel cage. After multiple pairings, rats will exhibit gaping behavior when placed in the context, even in the absence of the toxin51, 52 We used a high dose of LiCl that produces significant conditioned gaping 44, 5355.

We studied both male and female rats, given the female predominance of ANV and the relative paucity of data from females in the experimental literature. We monitored gaping after an acute dose of LiCl and in response to the LiCl-conditioned context. We then analyzed c-fos induction after acute LiCl and in response to the LiCl-conditioned environment. Areas analyzed included brain regions previously associated with LiCl and/or the acute vomiting reflex, including the AP, NTS, SON, and CeA, as well as brain regions that we anticipated would respond to the contextual stimulus, including the vmPFC, aIC, and PVN35, 5661. While the acute vomiting response is well-described in rats40, 62, 63, there is little data regarding the neural activation during the conditioned nausea response. We hypothesized that brain regions associated with the acute vomiting response would not be involved in the conditioned vomiting response.

Materials and Methods

Animals

Male and female Sprague Dawley rats (PN60, Charles River Laboratories, Raleigh, NC) were received 1 week before behavior tests. Rats were housed by sex in ventilated polypropylene cages (41 × 25 × 18 cm) in a colony room with a temperature of 21.1 ± 1.0 °C. They were given ad libitum access to food (Purina Lab Diet for rodents #5001) and water on a 12-hour light/dark cycle with lights on from 0700–1900. Humidity ranged from 30–70%. Cages were cleaned twice a week. Temperature and humidity were monitored automatically 24 hours/day and recorded daily. Females were randomly cycling and not selected based on estrous cycle stage. Cycle was determined in females by lavage on the day of behavioral testing. All studies were conducted in accordance with the Guide for Care and Use of Laboratory Animals and were approved by the Duke University IACUC protocol number A090-19-04.

Conditioned Nausea

The experimental design, based on the model described by Parker, et. al,51 is shown in Fig. 1A. On day 0, animals received 96 mg/kg LiCl (15.1 mL/kg of 0.15M, ip) or the equivalent of isotonic NaCl and placed in a novel polypropylene cage (35 × 25 × 13 cm). Gaping behavior was recorded for the first 10 minutes on an iPad placed beneath the clear plastic cage. Animals that were collected for acute condition were then perfused and brains collected for c-fos analysis.

Figure 1.

Figure 1.

(A) Experimental protocol for conditioned nausea. (B) Normal mouth position. (C) Gaping position (D) Gaping behavior by sex on days 0 and 8. N=8 for NaCl-treated males, n=5 for NaCl-treated females, n=10 for LiCl-treated males, n=11 for LiCl-treated females.

Animals taken through the conditioning protocol were given repeat injections of 96 mg/kg LiCl or the equivalent of NaCl and placed in the same context on alternate days for 4 conditioning sessions. Animals were weighed daily to monitor for excessive weight loss. Weights are listed in Table 1 below. On the drug-free test day, animals were placed in test cage for 60 minutes. Gaping behavior was recorded for the first 10 minutes in the test cage as on day 0. Rats were then perfused, and brains collected for c-fos analysis.

Table 1.

Average weights (g) on days 0 and 8

Males Females
Day 0 Day 8 Day 0 Day 8
NaCl 344±15 408±16 249±3 262±6
LiCl 405±29 443±25 233±8 244±8

Video scoring of gaping behavior

Videos collected from days 0 and 8 were analyzed for gaping behavior. The scorer was blinded to experimental condition. Gaping behavior was measured for the first 10 minutes in the test cage. The scorer counted individual gapes (Fig. 1B, C) and total number of gapes during the 10-minute period was calculated.

Drugs

LiCl was purchased from Sigma Aldrich (product number 203637). LiCl was dissolved in distilled sterile water to a concentration of 0.15M. Sterile isotonic saline (NaCl, 0.9%; 0.15M) was used as a control injection.

Transcardial perfusion and freezing of brains

Animals were deeply anesthetized with urethane (3 mg/kg). We used toe-pinch to test for responsiveness, administering additional urethane if necessary. Perfusion was performed using ice-cold 1X phosphate-buffered saline (PBS) to exsanguinate, followed by 4% paraformaldehyde (PFA) for fixation.

The brain was carefully removed and placed in a vial containing 4% PFA. Brains were stored at 4°C overnight, then cryoprotected for 3–7 days in 30% sucrose in 1X PBS solution at 4°C. Brains were rapidly frozen in 1:2 ratio of Tissue-Tek® OCT Freezing Media and 30% sucrose in EtOH/dry ice slurry and stored at −80°C until ready to be cut for c-fos analysis.

Immunohistochemistry

Brains were cut on a Leica CM3050S cryostat at 30 uM and stored in 1:1 TBS/glycerol solution at −20°C until ready to stain. To stain, slices were first washed in 0.2% Triton-X in Tris-buffered saline (TBS) solution 3 times × 10 minutes. Slices were then blocked for 1 hour in solution of 0.3% Triton-X and 5% normal goat serum (NGS) in PBS. Slices were stained overnight in 0.3% Triton-X, 5% NGS, and 1:20,000 anti-c-fos antibody (Abcam - ab190289) with gentle shaking at 4°C. Slices were then washed 3 times in solution of 0.3% Triton-X and 5% NGS in PBS (10 minutes first wash, 30 minutes second wash, 40 minutes third wash). Slices were then stained with secondary antibody (AlexaFluor 488, Invitrogen – A-11034) in 0.3% Triton-X, 5% NGS, and 1:200 secondary antibody for 2 hours. Slices were then washed in 1X PBS (10 minutes first wash, 30 minutes second wash, and 40 minutes third wash), with DAPI (R&D Systems 5748) added at a dilution of 1:10,000 for last 10 minutes of second wash. Slices were mounted on VWR Superfrost® Plus microscope slides with a drop of Vecta-Shield anti-fade medium (Vector Laboratories 101098-042).

Imaging and analysis

Slides were imaged with an Axio Imager upright microscope at 20x (16 z-stacks 2 uM apart) for IHC or 20x (8 z-stacks 1 uM apart) for RNAScope. Images were z-projected for max intensity using FIJI (ImageJ) software and Fos+ neurons were manually counted. 2–6 slices per region were imaged and counted per animal. Counts were averaged per animal. Brain region coordinates are described below:

Brain region Coordinates (mm from Bregma)
vmPFC +3.54 to +2.28
aIC, gIC, NAcC +2.28 to +1.44
SON −1.52 to −1.20
PVN −1.80 to −2.04
CeA, BLA −2.40 to −2.92
NTS −13.20 to −13.80
AP −13.68 to −14.16

Statistics

All results were analyzed by ANOVA with posthoc Fisher’s exact test corrected for multiple comparisons using the statistical package NCSS. Behavioral results were analyzed by 3-way ANOVA (sex × treatment × day) followed by lower order ANOVA for significant interactions. C-fos responses were analyzed by 3-way repeated measures ANOVA (sex and condition as between measures and brain area as repeated measure). Individual ANOVAs were also run for each brain area independently as area was a strong main effect in the 3-way ANOVA. N for all behavior and c-fos experiments was estimated by power analysis and estimated variance based on previous experience with CTA behavior and c-fos analysis of multiple brain regions 6467.

Results

LiCl produces robust conditioned gaping

We performed 3-way RMANOVA of sex × treatment × day for gaping on Day 0 and day 8 (Fig. 1D). We found a main effect of treatment [F(1, 29)=10.06, p=0.004], a main effect of day [F(1, 29)=9.87, p=0.004], and an interaction of treatment × day [F(1, 29)=10.28, p=0.003]. These results showed that LiCl-treated animals gaped day 8 but not on day 0, and that NaCl-treated controls did not gape significantly on either day. There was no effect of treatment × sex or sex × day.

On day 0, we found no effect of either treatment or sex. On day 8, we found a main effect of treatment [F(1,28)=14.37, p=<0.005], and no effect of sex or interaction of sex × treatment. Males and females did not differ significantly in their gaping behavior. The LiCl group gaped significantly more than NaCl control by Fisher’s posthoc.

The neural activation of acute and conditioned nausea

We performed immunohistochemistry (IHC) for c-fos in brain regions after acute NaCl or LiCl, and after conditioning with NaCl or LiCl (Table 2). We performed a repeated measures ANOVA (sex × treatment, area as repeated measure) on all conditions. We found a main effect of treatment [F(3, 38)=25.13, p=<0.001], a main effect of area [F(6, 37)=836.07, p=<0.001], an interaction of sex × area [F(10, 136)=28.12, p=<0.001], an interaction of treatment × area [F(18, 136)=43.37, p=<0.001], and a three-way interaction of treatment × sex × area [F(18, 136)=43.07, p=<0.001]. We then performed lower-level ANOVAs by brain areas individually.

Table 2.

c-fos±SEM in all brain regions

vmPFC aIC gIC NacC SON PVN BLA CeA NTS AP
Acute Male NaCl 320±17 211±14 114±19 96±22 11±4 266±92 40±14 45±9 39±3 26±2
LiCl 249±8 187±28 132±15 101±18 215±8 358±35 49±10 244±45 89±7 75±10
Female NaCl 340±10 288±35 100±31 200±33 17±4 217±69 40±12 66±21 25±7 15±7
LiCl 311±8 289±28 134±15 185±18 174±8 323±35 62±10 198±45 107±7 68±10
Conditioned Male NaCl 143±13 145±9 78±36 90±14 8±5 110±31 15±2 36±9 11±4 13±5
LiCl 241±9 210±10 75±18 100±17 14±7 160±12 32±5 42±11 16±3 10±1
Female NaCl 255±26 207±14 87±6 121±14 12±2 121±31 30±4 17±1 20±7 19±7
LiCl 231±16 221±10 60±17 126±17 15±5 93±16 38±6 27±8 5±1 3±1

Fig. 2 shows c-fos expression in the parts of the brain previously associated with acute nausea. The area postrema (AP) showed an effect of treatment [F(3, 22)=16.03, p=<0.001], with the acute LiCl condition showing increased expression compared to all other conditions. There was no increased expression in the conditioned LiCl rats (Fig. 2AC). We found a similar pattern in other parts of the brain associated with acute nausea. The nucleus tractus solitarius (NTS) showed an effect of treatment [F(3, 26)=63.66, p=<0.001], with only acute LiCl differing from all other conditions, and no increased expression the conditioned LiCl group (Fig. 2DF).

Figure 2.

Figure 2.

(A) c-fos activation of the AP in male and female rats in acute and conditioned context, n=3–6. (B) Atlas image of AP. (C) Representative images of the AP (D) c-fos activation of the NTS in male and female rats in acute and conditioned context, n=3–7. (E) Atlas image of NTS. (F) Representative images of the NTS. (G) c-fos activation of the CeA in male and female rats in acute and conditioned context, n=3–6. (H) Atlas image of CeA. (J) Representative images of the CeA (K) c-fos activation of the SON in male and female rats in acute and conditioned context, n=3–5. (L) Atlas image of SON (M) Representative images of the SON. Data shown as mean ± SEM.

The central nucleus of the amygdala (CeA) showed an effect of treatment [F(3, 24)=30.52, p=<0.001], with acute LiCl increased compared to all other groups, and no increased expression in the conditioned LiCl group (Fig. 2GJ).

The supraoptic nucleus (SON) showed an effect of treatment [F(3, 19)=530.05, p=<0.001], as well as an interaction of sex × treatment [F(3, 19)=7.82, p=0.001]. Males showed greater expression in the acute LiCl condition than females. There was no increase in c-fos in the conditioned LiCl group (Fig. 2KM).

Unlike the brain regions associated with the acute nausea circuit, the vmPFC, aIC, and PVN showed higher levels of c-fos expression in the conditioned LiCl context compared to the conditioned NaCl context in male rats, as shown in Figure 3. The vmPFC showed a main effect of sex [F(1, 30)=15.28, p=<0.001], a main effect of treatment [F(3, 30)=21.58, p=<0.001], and an interaction of treatment × sex [F(3, 30)=5.30, p=0.005]. Overall, c-fos in females was higher than males in the vmPFC. Males showed greater expression in the acute NaCl context compared to the acute LiCl context. Unlike areas profiled above, c-fos expression was higher in LiCl-conditioned males than NaCl-conditioned males. C-fos in females, in contrast, did not differ between the acute conditions (Fig. 3AC).

Figure 3.

Figure 3

(A) c-fos expression in the vmPFC in male and female rats in acute and conditioned context, n=4–6. (B) Atlas image of vmPFC. (C) Representative images of the vmPFC. (D) c-fos expression in the aIC in male and female rats in acute and conditioned context, n=4–6. (E) Atlas image of aIC. (F) Representative images of the aIC. (G) c-fos expression in the PVN in male and female rats in acute and conditioned context, n=3–6. (H) Atlas image of PVN. (J) Representative images. Data shown as mean ± SEM.

The agranular insula (aIC) showed a main effect of sex [F(1, 32)=20.88, p=<0.005], and a main effect of treatment [F(3, 32)=5.46, p=0.004]. C-fos in females was increased compared to males. There was no difference between acute NaCl and acute LiCl conditions in either sex. C-fos in the Conditioned LiCl group was increased compared to conditioned NaCl in males, but not females (Fig. 3DF).

The paraventricular nucleus (PVN) showed a main effect of treatment [F(3, 20)=9.83, p=<0.001]. There was no overall effect of sex. We then considered the acute and conditioned groups separately. The acute groups showed no differences between treatments. The conditioned groups showed an interaction of sex × treatment [F(3, 20)=9.83, p=<0.001]. C-fos in males showed an increase in the conditioned LiCl group compared to the conditioned NaCl group. C-fos in females in each group did not differ (Fig. 3GJ).

The nucleus accumbens core (NAc_C), granular insula (gIC), and basolateral nucleus of the amygdala (BLA) did not show a significant response to the acute or conditioned context, and so will not be discussed further.

Discussion

This behavioral paradigm produced robust CG in both male and female rats. LiCl induced similar levels of CG in male and female rats after 4 pairings with the contextual stimulus, while demonstrating minimal gaping behavior after the first exposure to LiCl. -fos experiments showed that the brain areas that are activated by acute LiCl are not activated during the conditioned response. Meanwhile, in male rats, brain regions that are responsive to novel context (i.e., activated in the acute condition by both NaCl and LiCl) continue to show high levels of c-fos activation on test day in the LiCl-paired context. Other studies support the role of the insula in this conditioned response 51, 6870. The present study expands these brain areas to include the ventromedial prefrontal cortex and paraventricular nucleus in male rats. C-fos in female rats likewise did not respond in brain regions associated with acute nausea (AP, NTS, SON, and CeA) in the conditioned task relative to the acute challenge but demonstrated habituation of the response to the cage (responses to both NaCl and LiCl) instead in the vmPFC, aIC, or PVN.

We speculate that the context previously associated with nausea triggers the gaping behavior without activating the acute nausea circuit. The contextual stimulus produced robust gaping behavior, while the brain regions normally responsible for initiating the vomiting reflex were silent. The novel context produced high levels of c-fos expression in the vmPFC, aIC, and PVN in both the NaCl- and LiCl-treated groups, but conditioned diminution of c-fos expression in the NaCl-associated context and conditioned activation in the LiCl treated male rats.

These results lay potential groundwork for further defining the neural substrates of conditioned nausea. Clarification of these substrates and cell-specific analyses will be useful in deepening our understanding of the neuronal subtypes that are activated by the contextual stimulus and promote the conditioned gaping response.

While males and females elicited similar conditioned gaping, the c-fos responses to the conditioned contexts differed by sex. Females showed neither an exaggerated c-fos response in brain regions after exposure to the conditioned environment nor habituation in the NaCl conditioned environment. In contrast, in males, c-fos expression in these brain regions (vmPFC, aIC, and PVN) showed habituation in the NaCl-associated conditioned context relative to the acute NaCl condition and higher c-fos expression was maintained in the LiCl-conditioned context. Further studies that assess a broader range of brain areas are necessary to determine whether this may be due to variances in c-fos expression due to estrous cycle or if other brain regions are responsible for the conditioned response in females.

An important area of further study is whether other long-term transcription factors may be present, such as ΔFosB, a member of the fos family of transcription factors that accumulates over time 7174. It is possible that longer term changes in neural activity may be reflected in different transcription factors.

The current study was limited by the subset of brain regions that are associated with caudal processing of the acute stimulus. The course of afferent acute stimuli is well characterized: it flows from the area postrema that we sampled, rostrally through the bed nucleus of the stria terminalis to the parabrachial nucleus and on to the visceral (granular) cortex 69. The present study was not a comprehensive study of enough areas to integrate the current findings with what is known about the neural circuit for the conditioned nausea response but it provides insight into core areas involved. Further studies would also benefit from cell-specific analysis of the insula in particular to determine whether the same cell types are responding to both the acute and conditioned stimuli. Studies show that the insula has a role in assessing toxic inputs 75, 76. Better characterization of the specific cell populations that respond to the acute and conditioned LiCl contexts could provide valuable insight into how the insula assesses visceral versus contextual stimuli. An additional caveat is that, since there is no control of animals receiving LiCl in their home cages, it is difficult to conclude that behavior and c-fos activation is due to the contextual stimulus.

Our studies showed that the neural activation occurring during conditioned gaping differs dramatically from that occurring during the acute stimulus with an emetogenic agent. Conditioning to contextual stimuli may contribute to the pathogenesis of ANV, which suggests that quite different pharmacotherapies might prove effective. It is known that aggressive anti-emetic therapy at the initiation of treatment is extremely important to prevent the development of ANV and has diminishing returns with repeated treatments 12, 32, 77, 78. Our study supports the finding that pharmacotherapy targeting brain regions associated with the acute vomiting stimulus is likely to be less effective for ANV. Further clarification of the circuit controlling the conditioned stimulus is important for laying a groundwork to better our understanding of this difficult disorder, and to has the potential to identify novel targets to improve pharmacotherapy.

Acknowledgements.

The authors gratefully acknowledge the financial support of the Duke University School of Medicine and GM007171 which provided support for Alyssa Bernanke.

References

  • 1.Cubeddu LX. Mechanisms by which cancer chemotherapeutic drugs induce emesis. Semin Oncol. 1992;19(6 Suppl 15):2–13. [PubMed] [Google Scholar]
  • 2.Bovbjerg DH, Redd WH, Jacobsen PB, Manne SL, Taylor KL, Surbone A, et al. An experimental analysis of classically conditioned nausea during cancer chemotherapy. Psychosom Med. 1992;54(6):623–37. [DOI] [PubMed] [Google Scholar]
  • 3.Naylor RJ, Rudd JA. Mechanisms of chemotherapy/radiotherapy-induced emesis in animal models. Oncology. 1996;53 Suppl 1:8–17. [DOI] [PubMed] [Google Scholar]
  • 4.Schnell FM. Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control. Oncologist. 2003;8(2):187–98. [DOI] [PubMed] [Google Scholar]
  • 5.Navari RM. Nausea and Vomiting in Advanced Cancer. Curr Treat Options Oncol. 2020;21(2):14. [DOI] [PubMed] [Google Scholar]
  • 6.Andrykowski MA. The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: a review and synthesis. Psychosom Med. 1990;52(4):458–75. [DOI] [PubMed] [Google Scholar]
  • 7.Watson M, McCarron J, Law M. Anticipatory nausea and emesis, and psychological morbidity: assessment of prevalence among out-patients on mild to moderate chemotherapy regimens. Br J Cancer. 1992;66(5):862–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Stockhorst U, Klosterhalfen S, Klosterhalfen W, Winkelmann M, Steingrueber HJ. Anticipatory nausea in cancer patients receiving chemotherapy: classical conditioning etiology and therapeutical implications. Integr Physiol Behav Sci. 1993;28(2):177–81. [DOI] [PubMed] [Google Scholar]
  • 9.Morrow GR, Rosenthal SN. Models, mechanisms and management of anticipatory nausea and emesis. Oncology. 1996;53 Suppl 1:4–7. [DOI] [PubMed] [Google Scholar]
  • 10.Morrow GR, Roscoe JA, Kirshner JJ, Hynes HE, Rosenbluth RJ. Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics. Support Care Cancer. 1998;6(3):244–7. [DOI] [PubMed] [Google Scholar]
  • 11.Zachariae R, Paulsen K, Mehlsen M, Jensen AB, Johansson A, von der Maase H. Anticipatory nausea: the role of individual differences related to sensory perception and autonomic reactivity. Ann Behav Med. 2007;33(1):69–79. [DOI] [PubMed] [Google Scholar]
  • 12.Akechi T, Okuyama T, Endo C, Sagawa R, Uchida M, Nakaguchi T, et al. Anticipatory nausea among ambulatory cancer patients undergoing chemotherapy: prevalence, associated factors, and impact on quality of life. Cancer Sci. 2010;101(12):2596–600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hilarius DL, Kloeg PH, van der Wall E, van den Heuvel JJ, Gundy CM, Aaronson NK. Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study. Support Care Cancer. 2012;20(1):107–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Navari RM, Qin R, Ruddy KJ, Liu H, Powell SF, Bajaj M, et al. Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting. N Engl J Med. 2016;375(2):134–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tienchaiananda P, Nipondhkit W, Maneenil K, Sa-Nguansai S, Payapwattanawong S, Laohavinij S, et al. A randomized, double-blind, placebo-controlled study evaluating the efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide. Ann Palliat Med. 2019;8(4):372–80. [DOI] [PubMed] [Google Scholar]
  • 16.Ithimakin S, Theeratrakul P, Laocharoenkiat A, Nimmannit A, Akewanlop C, Soparattanapaisarn N, et al. Randomized, double-blind, placebo-controlled study of aprepitant versus two dosages of olanzapine with ondansetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving high-emetogenic chemotherapy. Support Care Cancer. 2020. [DOI] [PubMed] [Google Scholar]
  • 17.Zhou JG, Huang L, Jin SH, Xu C, Frey B, Ma H, et al. Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials. ESMO Open. 2020;5(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hashimoto H, Abe M, Tokuyama O, Mizutani H, Uchitomi Y, Yamaguchi T, et al. Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2020;21(2):242–9. [DOI] [PubMed] [Google Scholar]
  • 19.Tyers MB, Bunce KT, Humphrey PP. Pharmacological and anti-emetic properties of ondansetron. Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S15–9. [PubMed] [Google Scholar]
  • 20.Naylor RJ, Rudd JA. Pharmacology of ondansetron. Eur J Anaesthesiol Suppl. 1992;6:3–10. [PubMed] [Google Scholar]
  • 21.Jovanovic-Micic D, Samardzic R, Beleslin DB. The role of alpha-adrenergic mechanisms within the area postrema in dopamine-induced emesis. Eur J Pharmacol. 1995;272(1):21–30. [DOI] [PubMed] [Google Scholar]
  • 22.Yoshikawa T, Yoshida N, Hosoki K. Involvement of dopamine D3 receptors in the area postrema in R(+)-7-OH-DPAT-induced emesis in the ferret. Eur J Pharmacol. 1996;301(1–3):143–9. [DOI] [PubMed] [Google Scholar]
  • 23.Board T, Board R. The role of 5-HT3 receptor antagonists in preventing postoperative nausea and vomiting. AORN J. 2006;83(1):209–16, 19–20. [DOI] [PubMed] [Google Scholar]
  • 24.Neufeld SM, Newburn-Cook CV. The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative nausea and vomiting after craniotomy: a meta-analysis. J Neurosurg Anesthesiol. 2007;19(1):10–7. [DOI] [PubMed] [Google Scholar]
  • 25.Smith HS, Cox LR, Smith EJ. 5-HT3 receptor antagonists for the treatment of nausea/vomiting. Ann Palliat Med. 2012;1(2):115–20. [DOI] [PubMed] [Google Scholar]
  • 26.Horn CC, Wallisch WJ, Homanics GE, Williams JP. Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting. Eur J Pharmacol. 2014;722:55–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Welliver M Dopamine antagonists for nausea and vomiting: special considerations. Gastroenterol Nurs. 2014;37(5):361–4. [DOI] [PubMed] [Google Scholar]
  • 28.Navari RM. 5-HT3 receptors as important mediators of nausea and vomiting due to chemotherapy. Biochim Biophys Acta. 2015;1848(10 Pt B):2738–46. [DOI] [PubMed] [Google Scholar]
  • 29.Wolfe RC, Bequette J. Dopamine Receptor Antagonists for the Prevention and Treatment of Postoperative Nausea and Vomiting. J Perianesth Nurs. 2021;36(2):199–202. [DOI] [PubMed] [Google Scholar]
  • 30.Rock EM, Sticht MA, Limebeer CL, Parker LA. Cannabinoid Regulation of Acute and Anticipatory Nausea. Cannabis Cannabinoid Res. 2016;1(1):113–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Rock EM, Limebeer CL, Navaratnam R, Sticht MA, Bonner N, Engeland K, et al. A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping. Psychopharmacology (Berl). 2014;231(16):3207–15. [DOI] [PubMed] [Google Scholar]
  • 32.Kamen C, Tejani MA, Chandwani K, Janelsins M, Peoples AR, Roscoe JA, et al. Anticipatory nausea and vomiting due to chemotherapy. Eur J Pharmacol. 2014;722:172–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Rock EM, Limebeer CL, Aliasi-Sinai L, Parker LA. The ventral pallidum as a critical region for fatty acid amide hydrolase inhibition of nausea-induced conditioned gaping in male Sprague-Dawley rats. Neuropharmacology. 2019;155:142–9. [DOI] [PubMed] [Google Scholar]
  • 34.Bolognini D, Rock EM, Cluny NL, Cascio MG, Limebeer CL, Duncan M, et al. Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. Br J Pharmacol. 2013;168(6):1456–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Olson BR, Freilino M, Hoffman GE, Stricker EM, Sved AF, Verbalis JG. c-Fos Expression in Rat Brain and Brainstem Nuclei in Response to Treatments That Alter Food Intake and Gastric Motility. Mol Cell Neurosci. 1993;4(1):93–106. [DOI] [PubMed] [Google Scholar]
  • 36.Sakai N, Yamamoto T. Conditioned taste aversion and c-fos expression in the rat brainstem after administration of various USs. Neuroreport. 1997;8(9–10):2215–20. [DOI] [PubMed] [Google Scholar]
  • 37.Swank MW, Schafe GE, Bernstein IL. c-Fos induction in response to taste stimuli previously paired with amphetamine or LiCl during taste aversion learning. Brain Res. 1995;673(2):251–61. [DOI] [PubMed] [Google Scholar]
  • 38.Thiele TE, Roitman MF, Bernstein IL. c-Fos induction in rat brainstem in response to ethanol- and lithium chloride-induced conditioned taste aversions. Alcohol Clin Exp Res. 1996;20(6):1023–8. [DOI] [PubMed] [Google Scholar]
  • 39.Yamamoto T, Shimura T, Sako N, Azuma S, Bai WZ, Wakisaka S. C-fos expression in the rat brain after intraperitoneal injection of lithium chloride. Neuroreport. 1992;3(12):1049–52. [DOI] [PubMed] [Google Scholar]
  • 40.Hornby PJ. Central neurocircuitry associated with emesis. Am J Med. 2001;111 Suppl 8A:106S–12S. [DOI] [PubMed] [Google Scholar]
  • 41.Sato T, Hirai Y, Su S, Zimo W, Yasuura N, Inui T, et al. Involvement of the area postrema and the nucleus tractus solitarius in the emetogenic action of emetine in rats. J Oral Biosci. 2020;62(4):310–4. [DOI] [PubMed] [Google Scholar]
  • 42.Watson PJ, Leitner C. Patterns of increased and decreased ingestive behavior after injections of lithium chloride and 2-deoxy-D-glucose. Physiol Behav. 1988;43(6):697–704. [DOI] [PubMed] [Google Scholar]
  • 43.Bernstein IL, Chavez M, Allen D, Taylor EM. Area postrema mediation of physiological and behavioral effects of lithium chloride in the rat. Brain Res. 1992;575(1):132–7. [DOI] [PubMed] [Google Scholar]
  • 44.Cloutier CJ, Cross-Mellor SK, Kavaliers M, Ossenkopp KP. Simultaneous conditioning of “gaping” responses and taste avoidance in rats injected with LiCl and saccharin: examining the role of context and taste cues in the rodent model of anticipatory nausea. Neurosci Lett. 2011;502(2):76–9. [DOI] [PubMed] [Google Scholar]
  • 45.Meachum CL, Bernstein IL. Conditioned responses to a taste conditioned stimulus paired with lithium chloride administration. Behav Neurosci. 1990;104(5):711–5. [DOI] [PubMed] [Google Scholar]
  • 46.Tuerke KJ, Winters BD, Parker LA. Ondansetron interferes with unconditioned lying-on belly and acquisition of conditioned gaping induced by LiCl as models of nausea-induced behaviors in rats. Physiol Behav. 2012;105(3):856–60. [DOI] [PubMed] [Google Scholar]
  • 47.Horn CC, Kimball BA, Wang H, Kaus J, Dienel S, Nagy A, et al. Why can’t rodents vomit? A comparative behavioral, anatomical, and physiological study. PLoS One. 2013;8(4):e60537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Limebeer CL, Hall G, Parker LA. Exposure to a lithium-paired context elicits gaping in rats: A model of anticipatory nausea. Physiol Behav. 2006;88(4–5):398–403. [DOI] [PubMed] [Google Scholar]
  • 49.Limebeer CL, Krohn JP, Cross-Mellor S, Litt DE, Ossenkopp KP, Parker LA. Exposure to a context previously associated with nausea elicits conditioned gaping in rats: a model of anticipatory nausea. Behav Brain Res. 2008;187(1):33–40. [DOI] [PubMed] [Google Scholar]
  • 50.Travers JB, Norgren R. Electromyographic analysis of the ingestion and rejection of sapid stimuli in the rat. Behav Neurosci. 1986;100(4):544–55. [DOI] [PubMed] [Google Scholar]
  • 51.Parker LA, Limebeer CL. Conditioned gaping in rats: a selective measure of nausea. Auton Neurosci. 2006;129(1–2):36–41. [DOI] [PubMed] [Google Scholar]
  • 52.Parker LA, Rock EM, Sticht MA, Wills KL, Limebeer CL. Cannabinoids suppress acute and anticipatory nausea in preclinical rat models of conditioned gaping. Clin Pharmacol Ther. 2015;97(6):559–61. [DOI] [PubMed] [Google Scholar]
  • 53.Cloutier CJ, Kavaliers M, Ossenkopp KP. Rodent sex differences in disgust behaviors (anticipatory nausea) conditioned to a context associated with the effects of the toxin LiCl: Inhibition of conditioning following immune stimulation with lipopolysaccharide. Pharmacol Biochem Behav. 2017;152:4–12. [DOI] [PubMed] [Google Scholar]
  • 54.Cloutier CJ, Zevy DL, Kavaliers M, Ossenkopp KP. Conditioned disgust in rats (anticipatory nausea) to a context paired with the effects of the toxin LiCl: Influence of sex and the estrous cycle. Pharmacol Biochem Behav. 2018;173:51–7. [DOI] [PubMed] [Google Scholar]
  • 55.Cloutier CJ, Kavaliers M, Ossenkopp KP. Lipopolysaccharide (LPS) induced sickness in adolescent female rats alters the acute-phase response and lithium chloride (LiCl)- induced impairment of conditioned place avoidance/aversion learning, following a homotypic LPS challenge in adulthood. Behav Brain Res. 2018;351:121–30. [DOI] [PubMed] [Google Scholar]
  • 56.Lamprecht R, Dudai Y. Transient expression of c-Fos in rat amygdala during training is required for encoding conditioned taste aversion memory. Learn Mem. 1996;3(1):31–41. [DOI] [PubMed] [Google Scholar]
  • 57.Lamprecht R, Dudai Y. Differential modulation of brain immediate early genes by intraperitoneal LiCl. Neuroreport. 1995;7(1):289–93. [PubMed] [Google Scholar]
  • 58.Spencer CM, Eckel LA, Nardos R, Houpt TA. Area postrema lesions attenuate LiCl-induced c-Fos expression correlated with conditioned taste aversion learning. Physiol Behav. 2012;105(2):151–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Spencer CM, Houpt TA. Dynamics of c-fos and ICER mRNA expression in rat forebrain following lithium chloride injection. Brain Res Mol Brain Res. 2001;93(2):113–26. [DOI] [PubMed] [Google Scholar]
  • 60.Olszewski PK, Shi Q, Billington CJ, Levine AS. Opioids affect acquisition of LiCl-induced conditioned taste aversion: involvement of OT and VP systems. Am J Physiol Regul Integr Comp Physiol. 2000;279(4):R1504–11. [DOI] [PubMed] [Google Scholar]
  • 61.Rinaman L, Dzmura V. Experimental dissociation of neural circuits underlying conditioned avoidance and hypophagic responses to lithium chloride. Am J Physiol Regul Integr Comp Physiol. 2007;293(4):R1495–503. [DOI] [PubMed] [Google Scholar]
  • 62.Billig I, Yates BJ, Rinaman L. Plasma hormone levels and central c-Fos expression in ferrets after systemic administration of cholecystokinin. Am J Physiol Regul Integr Comp Physiol. 2001;281(4):R1243–55. [DOI] [PubMed] [Google Scholar]
  • 63.Andrews PL, Horn CC. Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases. Auton Neurosci. 2006;125(1–2):100–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Radulovic J, Kammermeier J, Spiess J. Relationship between fos production and classical fear conditioning: effects of novelty, latent inhibition, and unconditioned stimulus preexposure. J Neurosci. 1998;18(18):7452–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Koh MT, Clarke SN, Spray KJ, Thiele TE, Bernstein IL. Conditioned taste aversion memory and c-Fos induction are disrupted in RIIbeta-protein kinase A mutant mice. Behav Brain Res. 2003;143(1):57–63. [DOI] [PubMed] [Google Scholar]
  • 66.Cason AM, Kwon B, Smith JC, Houpt TA. c-Fos induction by a 14 T magnetic field in visceral and vestibular relays of the female rat brainstem is modulated by estradiol. Brain Res. 2010;1347:48–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Chen K, Yan J, Li J, Lv B, Zhao X. c-Fos expression in rat brainstem following intake of sucrose or saccharin. Front Med. 2011;5(3):294–301. [DOI] [PubMed] [Google Scholar]
  • 68.Parker LA, Rock EM, Limebeer CL. Regulation of nausea and vomiting by cannabinoids. Br J Pharmacol. 2011;163(7):1411–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Parker LA. Conditioned flavor avoidance and conditioned gaping: rat models of conditioned nausea. Eur J Pharmacol. 2014;722:122–33. [DOI] [PubMed] [Google Scholar]
  • 70.Parker L, Rock E, Sticht M, Wills K, Limebeer C. Cannabinoids suppress acute and anticipatory nausea in preclinical rat models of conditioned gaping. Clinical Pharmacology & Therapeutics. 2015;97(6):559–61. [DOI] [PubMed] [Google Scholar]
  • 71.Renthal W, Carle TL, Maze I, Covington HE 3rd, Truong HT, Alibhai I, et al. Delta FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure. J Neurosci. 2008;28(29):7344–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Hedges VL, Chakravarty S, Nestler EJ, Meisel RL. Delta FosB overexpression in the nucleus accumbens enhances sexual reward in female Syrian hamsters (vol 8, pg 442, 2009). Genes Brain and Behavior. 2009;8(7):733-. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Robison AJ, Nestler EJ. Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci. 2011;12(11):623–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Sterrenburg L, Gaszner B, Boerrigter J, Santbergen L, Bramini M, Roubos EW, et al. Sex-dependent and differential responses to acute restraint stress of corticotropin-releasing factor-producing neurons in the rat paraventricular nucleus, central amygdala, and bed nucleus of the stria terminalis. J Neurosci Res. 2012;90(1):179–92. [DOI] [PubMed] [Google Scholar]
  • 75.Wright P, He G, Shapira NA, Goodman WK, Liu Y. Disgust and the insula: fMRI responses to pictures of mutilation and contamination. Neuroreport. 2004;15(15):2347–51. [DOI] [PubMed] [Google Scholar]
  • 76.Holtmann O, Bruchmann M, Monig C, Schwindt W, Melzer N, Miltner WHR, et al. Lateralized Deficits of Disgust Processing After Insula-Basal Ganglia Damage. Front Psychol. 2020;11:1429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Roscoe JA, Morrow GR, Aapro MS, Molassiotis A, Olver I. Anticipatory nausea and vomiting. Support Care Cancer. 2011;19(10):1533–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Dupuis LL, Robinson PD, Boodhan S, Holdsworth M, Portwine C, Gibson P, et al. Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients. Pediatr Blood Cancer. 2014;61(8):1506–12. [DOI] [PubMed] [Google Scholar]

RESOURCES